Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Re-Examine the Sun...

    Re-Examine the Sun Pharma Medical Rep Transfer issue in Six months: Bombay HC

    Written by Geeta Sharma Sharma Published On 2016-05-04T14:56:46+05:30  |  Updated On 4 May 2016 2:56 PM IST
    Re-Examine the Sun Pharma Medical Rep Transfer issue in Six months: Bombay HC
    Bombay High-Court has Instructed the Industrial court to examine Sun Pharma MR transfer issue within 6-months

    Sun Pharmaceutical Industry’s move to transfer 54 medical representatives has been taken up by the Bombay High court. It has instructed the industrial court to look into the charges of those who claim to be forcefully transferred by the company.

    The industrial court had dismissed the appeal filed by the Federation of Medical and Sales Association of India to block the transfers, earlier this year. The plea being that the matter did not fall under its jurisdiction, which fell under the Maharashtra Recognition of Trade Unions and Prevention of Unfair labour Practices Act.

    The industrial court has now been directed by the High court to finalize the matter within six months, according to sources. The dispute between Sun Pharma and the medical representatives erupted last year when the company was in the process of taking over Ranbaxy and on completion had got into the process of integrating commercial operations of both the companies reported ET.

    Sun Pharma revealed that the decision taken was in concurrence with the conclusions reached with the union.

    55 medical representativesBombay High CourtFederation of Medical and Sales Association of Indiaforceful transferIndustrial Courtmedical representativesSun Pharma
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok